Source: Business Wire
Epiq Animal Health and KeraVet Bio have partnered to launch KeraVet Gel, an innovative wound care product for dogs and cats. KeraVet Gel, a reformulation of the FDA-cleared human product KeraStat Gel, includes a bitterant to reduce licking by over 85%. This gel promotes faster wound healing and reduces the need for E-collars, enhancing pet owner compliance and patient outcomes. Suitable for various wounds, KeraVet Gel simplifies wound care for both clinics and pet owners by eliminating the need for multiple products.
The partnership streamlines supply chain solutions and provides education and training to the animal health community. Epiq’s support includes inventory and account management, benefiting distribution partners and veterinarians by ensuring access to high-quality products. KeraVet Gel is now available through animal health distribution channels. For more information, visit keravetbio.com or email contact@epiq-ah.com.